PHARMA MARKET ACCESS

Is your Market Access engine driving measurable impact?

Equip your Market Access teams with the technology, data, and insights needed to deliver value in an increasingly evidence-based, risk-averse landscape. Engage with our strategic experts, and benefit from our proven innovations.

Locations United States Our U.S. Solutions Life Sciences Commercial Solutions Market Access Solutions

Are margin pressures eroding your pharma profitability?

IQVIA empowers pharma market access teams to improve margins, reduce risk, and drive smarter contract decisions with unparalleled data, tech-enabled workflows, and advanced analytics for 340B compliance and rebate management.

Build accurate GTN accruals with unified data

IQVIA's Orchestrated Gross-to-Net platform provides unified, claim-level insights across geographies and contracts. Our platform is designed specifically for pharma financial planning, it integrates accruals, reserve insights, and variance analysis.

OPTIMIZE GTN

$147.8B 340B exposure

Anticipate impacts of evolving state 340B policy legislation through customizable analytics by brand and geography.

TRACK 340b RISK

Detect duplicate discounts and strengthen audit readiness

Identify at-risk claims through enriched rebate and site-of-care data. Reduce revenue leakage caused by duplicate payments and incorrect pricing and analyze contract exposure trends from state-level law changes.

STOP LEAKAGE

Scale Model N implementations with proven expertise

Leverage 30+ Model N implementations and years of combined experience. Our team completed 3,000+ pricing configuration requirements in 13 months and reduced interfaces by 50%, creating more efficient, scalable infrastructure.

SCALE PRICING

WHITE PAPER

Can IQVIA help identify my 340B policy exposure?

IQVIA quantifies state 340B costs and delivers data to inform advocacy and mitigate portfolio impact. With insights into state laws and per-beneficiary exposure, you can quantify risk, align internal stakeholders, and prioritize policy engagement. Dive into the details.

ACCESS THE WHITE PAPER

30+

Model N implementations and decades of pricing expertise prove IQVIA’s unmatched depth in pharma systems integration.

$147.8B

In 340B volume tracked enables pharma teams to quantify exposure and plan with confidence.

Dig deeper into pharma market access

Stay a step ahead of data quality issues

From setting clear standards to training teams with tools to enrich the data, we’ve got you covered with expert guidance.

Get your brief

Explore the latest insights for Pharma Market Access

Pharma Market Access Blog

Explore expert blogs covering the latest trends in pharma market access, and the dynamic market forces shaping the U.S. healthcare landscape.

READ THE BLOG

Insights Library

Visit our insight library to learn more about 340B, rebates, contract strategy, and other key topics related to modern market access.

GET MORE INSIGHTS

Frequently Asked Questions

IQVIA’s Orchestrated GTN platform provides a single source of truth for rebate, accrual, and forecasting data. This supports more accurate pharma financial planning and scenario modeling. Embedded modeling, variance analysis, and persona-driven dashboards help drive smarter, faster decisions.

Our 340B Dynamics Dashboard helps pharma teams stay compliant and reduce margin loss. Reveal brand-level exposure and assess policy risk with this customizable tool. Reliable analytics and visuals support, risk mitigation, and planning across geography, brand, and channels.

IQVIA's Enhanced Rebate Master Data Management solution enriches rebate claims using site-of-care, NPI, and policy-aware data. It flags duplicate discounts, identifies at-risk claims, and improves audit readiness, which helps pharma reduce revenue leakage from hidden 340B exposures.

IQVIA's Managed Services provide a full suite of capabilities to support your unique managed market needs. Our deep expertise and advanced analytics help clients address challenges including rebate invoice validation, Medicaid dispute identification and resolution, and other complex issues.

IQVIA quantifies state 340B costs and delivers data to inform advocacy and mitigate portfolio impact. With insights into state laws and per-beneficiary exposure up to $213, you can quantify risk, align internal stakeholders, and prioritize policy engagement. Dive into the details.